Folgen
Claus-Michael Lehr
Claus-Michael Lehr
Helmholtz Inst. Pharm. Research Saarland (HIPS)
Bestätigte E-Mail-Adresse bei helmholtz-hzi.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
CM Lehr, JA Bouwstra, EH Schacht, HE Junginger
International journal of Pharmaceutics 78 (1-3), 43-48, 1992
13681992
Diverse applications of nanomedicine
B Pelaz, C Alexiou, RA Alvarez-Puebla, F Alves, AM Andrews, S Ashraf, ...
ACS nano 11 (3), 2313-2381, 2017
13592017
Towards the sustainable discovery and development of new antibiotics
M Miethke, M Pieroni, T Weber, M Brönstrup, P Hammann, L Halby, ...
Nature Reviews Chemistry 5 (10), 726-749, 2021
8712021
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
MNVR Kumar, U Bakowsky, CM Lehr
Biomaterials 25 (10), 1771-1777, 2004
7172004
Nanoparticles–an efficient carrier for drug delivery into the hair follicles
J Lademann, H Richter, A Teichmann, N Otberg, U Blume-Peytavi, ...
European Journal of Pharmaceutics and Biopharmaceutics 66 (2), 159-164, 2007
7062007
Size-dependent bioadhesion of micro-and nanoparticulate carriers to the inflamed colonic mucosa
A Lamprecht, U Schäfer, CM Lehr
Pharmaceutical research 18, 788-793, 2001
6402001
Lectin-mediated drug targeting: history and applications
C Bies, CM Lehr, JF Woodley
Advanced drug delivery reviews 56 (4), 425-435, 2004
5972004
Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease
ALF Lamprecht, N Ubrich, H Yamamoto, U Schäfer, H Takeuchi, ...
Journal of Pharmacology and Experimental Therapeutics 299 (2), 775-781, 2001
5402001
The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
G Borchard, HL Lueβen, AG de Boer, JC Verhoef, CM Lehr, HE Junginger
Journal of controlled release 39 (2-3), 131-138, 1996
5231996
A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro
C Kneuer, M Sameti, U Bakowsky, T Schiestel, H Schirra, H Schmidt, ...
Bioconjugate Chemistry 11 (6), 926-932, 2000
4652000
Lectin-mediated drug delivery:: The second generation of bioadhesives
CM Lehr
Journal of Controlled Release 65 (1-2), 19-29, 2000
4602000
The human epidermis models EpiSkin®, SkinEthic® and EpiDerm®: An evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance …
F Netzlaff, CM Lehr, PW Wertz, UF Schaefer
European Journal of Pharmaceutics and Biopharmaceutics 60 (2), 167-178, 2005
4462005
Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA
C Kneuer, M Sameti, EG Haltner, T Schiestel, H Schirra, H Schmidt, ...
International journal of pharmaceutics 196 (2), 257-261, 2000
4212000
Selective follicular targeting by modification of the particle sizes
A Patzelt, H Richter, F Knorr, U Schäfer, CM Lehr, L Dähne, W Sterry, ...
Journal of controlled release 150 (1), 45-48, 2011
3772011
Nanoparticle geometry and surface orientation influence mode of cellular uptake
H Herd, N Daum, AT Jones, H Huwer, H Ghandehari, CM Lehr
ACS nano 7 (3), 1961-1973, 2013
3532013
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides
N Nafee, S Taetz, M Schneider, UF Schaefer, CM Lehr
Nanomedicine: Nanotechnology, Biology and Medicine 3 (3), 173-183, 2007
3482007
Nanoparticles made from novel starch derivatives for transdermal drug delivery
MJ Santander-Ortega, T Stauner, B Loretz, JL Ortega-Vinuesa, ...
Journal of controlled release 141 (1), 85-92, 2010
3472010
Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity
EM Collnot, C Baldes, MF Wempe, R Kappl, J Hüttermann, JA Hyatt, ...
Molecular pharmaceutics 4 (3), 465-474, 2007
3352007
Pulmonary drug delivery: from generating aerosols to overcoming biological barriers—therapeutic possibilities and technological challenges
CA Ruge, J Kirch, CM Lehr
The lancet Respiratory medicine 1 (5), 402-413, 2013
3142013
Mucus as a barrier to lipophilic drugs
HH Sigurdsson, J Kirch, CM Lehr
International journal of pharmaceutics 453 (1), 56-64, 2013
3122013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20